Researchers
Lazarević, Slavica
Issue Date | Title | Author(s) | Type | М-cat. |
---|---|---|---|---|
2021 | Probiotic impact on gliclazide permeability (✓) | Đanić, Maja ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2021 | In Silico Analysis of Keto Derivatives of Bile Acids as Cardioprotective TGR5 Activators (✓) | Pavlović, Nebojša ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2021 | Gut Microbiota Generated Metabolites of Simvastatin (✓) | Đanić,Maja ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2021 | PAMPA model of gliclazide permeability: The impact of probiotic bacteria and bile acids (✓) | Đanić, Maja ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2021 | Cardioprotective Potential of Semisynthetic Bile Acids – Rational Drug Design (✓) | Lazarević, Slavica ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2019 | Gut microflora affects therapeutic effects of drugs (✓) | Đanić, Maja ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2019 | Methotrexate pharmacokinetics elucidation as the key factor in refinement therapy for acute lymphoblastic leukemia (✓) | Lazarević, Slavica ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2019 | Semisynthetic bile acids: a new therapeutic option for metabolic syndrome (✓) | Lazarević, Slavica ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21aM21a |
2019 | Lekovi u prometu 2019 : priručnik o lekovima i njihovoj primeni (✓) | Sabo, Ana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Milijašević, Boris
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Other | Mp. category will be shown later |
2019 | Procena inhibitorne aktivnosti metabolita gliklazida nastalih aktivnošću crevne mikroflore prema citohromima P450 (✓) | Pavlović, Nebojša ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2019 | Methotrexate: new research aspects for improved clinical response in childhood acute lymphoblastic leukemia (✓) | Lazarević, Slavica ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2019 | CYP inhibition assessment of gut microbiota-derived metabolites of - gliclazide (✓) | Pavlović, Nebojša ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2019 | In silico analysis of gliclazide metabolites produced by enzymatic activity of probiotic bacteria (✓) | Đanić, Maja ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2018 | Prevalence and predictors of self-medication among medical and pharmacy students (✓) | Tomas, Ana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2018 | Pre- vs. post-treatment with melatonin in CCl4-induced liver damage: Oxidative stress inferred from biochemical and pathohistological studies (✓) | Ničković, Vanja P.; Novaković, Tatjana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2018 | Preliminary study on gliclazide–probiotic bacteria interactions in in vitro conditions | ĐANIĆ, MAJA P. ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2018 | Interakcije između gliklazida i probiotskih bakterija u in vitro uslovima (✓) | Đanić, Maja ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2018 | 12-MKH: novi pristup u terapiji metaboličkog sindroma (✓) | Lazarević, Slavica ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2018 | 12-Monoketocholate: a new perspective in metabolic syndrome treatments | LAZAREVIĆ, SLAVICA ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2018 | Medical students' knowledge and attitudes regarding medical cannabis (✓) | Paut Kusturica, MIlica ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |